MAIA Biotechnology Inc (MAIA)
3.28
+0.13
(+4.13%)
USD |
NYAM |
May 03, 16:00
3.22
-0.06
(-1.83%)
After-Hours: 20:00
MAIA Biotechnology Cash and Short Term Investments (Quarterly): 7.151M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.151M |
| September 30, 2023 | 6.105M |
| June 30, 2023 | 9.146M |
| March 31, 2023 | 7.586M |
| December 31, 2022 | 10.95M |
| Date | Value |
|---|---|
| September 30, 2022 | 14.06M |
| June 30, 2022 | 8.15M |
| March 31, 2022 | 10.29M |
| December 31, 2021 | 10.57M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.105M
Minimum
Sep 2023
14.06M
Maximum
Sep 2022
9.336M
Average
9.146M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 3.378M |
| Avid Bioservices Inc | 30.71M |
| Oragenics Inc | 3.484M |
| NeuBase Therapeutics Inc | 12.57M |
| Viking Therapeutics Inc | 962.98M |